Condition

Axillary Metastases clinical trials and research

As of November 12, 2026, Find a Trial lists 3 Axillary Metastases clinical trials that are recruiting, at sites in 3 countries (most in Spain (1), Canada (1), United Kingdom (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest Axillary Metastases clinical trials

StudyPhaseWhereStatusRegistered
Targeted sentinel node biopsy for breast cancer patients with limited axillary nodal disease — Burnley and 13 other locations Recruiting Jul 25, 2025
Comparing ICG and Blue Patent for Axillary Dissection in Breast Cancer — L'Hospitalet de Llobregat, Barcelona Recruiting Apr 1, 2024
Targeted Axillary Dissection for Early-stage Breast Cancer — Montreal, Quebec and 2 other locations Recruiting Dec 17, 2020

All recruiting trials (3)

Related topics

Breast CancerBreastBreast Cancer FemaleEarly-stage Breast CancerLymph Node MetastasesNode-positive Breast CancerSentinel Lymph NodeSentinel Lymph Node Biopsy (SLNB)

Quick answers

How many Axillary Metastases clinical trials are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 3 countries. The most sites are in Spain (1 trial), Canada (1 trial), United Kingdom (1 trial). Each study page lists its sites and which ones are recruiting.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.